Keywords: آنتی بادی درمان; EMP2; Glioblastoma; Antibody therapy; Epithelial membrane protein 2;
مقالات ISI آنتی بادی درمان (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: آنتی بادی درمان; High mobility group box 1; Parkinson's disease; Neuroprotection; Inflammation; Antibody therapy; Blood–brain-barrier
Keywords: آنتی بادی درمان; Cutaneous lymphoma; Antibody therapy; Antibody conjugates; Clinical trials;
Keywords: آنتی بادی درمان; Claudin; Tight junction; Antibody therapy; Microenvironment; MIUC; muscle invasive urothelial cancers; CLDN; claudin; SPR; surface plasmon resonance; CDDP; cisplatinum; EGFR; epidermal growth factor receptor; ERK; extracellular signal-regulated kinase; EG
Efficacy of annexin A3 blockade in sensitizing hepatocellular carcinoma to sorafenib and regorafenib
Keywords: آنتی بادی درمان; Sorafenib resistance; Regorafenib; Liver cancer; ANXA3; Antibody therapy;
CD47 limits antibody dependent phagocytosis against non-malignant B cells
Keywords: آنتی بادی درمان; ADCP; antibody dependent cellular phagocytosis; hCD19 Tg; human CD19 transgenic; mAb; monoclonal antibody; SRBC; sheep red blood cells; CD47; CD19; B cell depletion; Antibody mediated phagocytosis; Knockout mice; Antibody therapy;
Therapeutic antibody targeting of indoleamine-2,3-dioxygenase (IDO2) inhibits autoimmune arthritis
Keywords: آنتی بادی درمان; Experimental arthritis; Antibody therapy; IDO; Murine model; B cells;
3B11-N, a monoclonal antibody against MERS-CoV, reduces lung pathology in rhesus monkeys following intratracheal inoculation of MERS-CoV Jordan-n3/2012
Keywords: آنتی بادی درمان; MERS-CoV; Antibody therapy; Animal model, MERS; Respiratory syndrome; Human monoclonal antibody therapy;
Enhanced immunotherapy of SM5-1 in hepatocellular carcinoma by conjugating with gold nanoparticles and its in vivo bioluminescence tomographic evaluation
Keywords: آنتی بادی درمان; Antibody therapy; Gold nanoparticles; Hepatocellular carcinoma; Cell proliferation; Bioluminescence tomography;
IgA as therapeutic antibody
Keywords: آنتی بادی درمان; Antibody therapy; IgA; Immunotherapy
Antibody mediated therapy targeting CD47 inhibits tumor progression of hepatocellular carcinoma
Keywords: آنتی بادی درمان; CD47; HCC; Antibody therapy; Xenograft models; CD47mAb400; CD47 monoclonal antibody (Clone 400); CFSE; carboxy fluorescein diacetate succinimidyl ester; H3B; Hep3B; HCC; hepatocelluar carcinoma; MTT; 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium br
Immunoglobulin Fc-fused, neuropilin-1-specific peptide shows efficient tumor tissue penetration and inhibits tumor growth via anti-angiogenesis
Keywords: آنتی بادی درمان; Antibody therapy; Tumor penetration; Tumor targeting, Neuropilin-1; Fc-fusion peptide; Anti-angiogenesis
Alemtuzumab for Severe Steroid-Refractory Gastrointestinal Acute Graft-versus-Host Disease
Keywords: آنتی بادی درمان; Allogeneic hematopoietic cell transplantation; Acute graft-versus-host disease; Antibody therapy; Alemtuzumab
Lack of clinical association and effect of peripheral WBC counts on immune cell function test in kidney transplant recipients with T-cell depleting induction and steroid-sparing maintenance therapy
Keywords: آنتی بادی درمان; Kidney transplant; ImmuKnow; Cylex; Rejection; Infection; Antibody therapy
Tapping the treasure of intracellular oncotargets with immunotherapy
Keywords: آنتی بادی درمان; Cancer; Immunotherapy; Antibody therapy; Vaccination; Extracellular receptor; Intracellular oncotarget
Anti-tumor activity of human IgG1 anti-gp75 TA99 mAb against B16F10 melanoma in human FcgammaRI transgenic mice
Keywords: آنتی بادی درمان; Antibody therapy; Melanoma; gp75; TA99; Fc receptor
The receptor for advanced glycation end products influences the expression of its S100 protein ligands in melanoma tumors
Keywords: آنتی بادی درمان; Melanoma; RAGE; S100B; Dacarbazine; Antibody therapy;
Boosting ADCC and CDC activity by Fc engineering and evaluation of antibody effector functions
Keywords: آنتی بادی درمان; ADCC; CDC; Antibody engineering; Fc modification; Antibody glycosylation; Antibody therapy;
Antibody mediated CDCP1 degradation as mode of action for cancer targeted therapy
Keywords: آنتی بادی درمان; CDCP1; Src; Antibody therapy; Contact inhibition
A humanised murine monoclonal antibody protects mice from Venezuelan equine encephalitis virus, Everglades virus and Mucambo virus when administered up to 48 h after airborne challenge
Keywords: آنتی بادی درمان; Venezuelan equine encephalitis virus; Everglades virus; Mucambo virus; Antibody therapy; Humanised antibody
A novel antibody targeting the ligand binding domain of the thromboxane A2 receptor exhibits antithrombotic properties in vivo
Keywords: آنتی بادی درمان; Thromboxane A2 receptor; Antibody therapy; Hemostasis; Thrombosis; Antithrombotic agents; Platelets
Tolerance induction with T cell-dependent protein antigens induces regulatory sialylated IgGs
Keywords: آنتی بادی درمان; Tolerance; IgG antibodies; IgG sialylation; dendritic cells; allergy; asthma; antigen-specific immunotherapy; antigen-specific tolerance; antibody therapy; CFA; Complete Freund adjuvant; DC; Dendritic cell; DTH; Delayed-type hypersensitivity; IVIG; Intrav
Development of a quantitative, cell-line based assay to measure ADCC activity mediated by therapeutic antibodies
Keywords: آنتی بادی درمان; Antibody-dependent cellular cytotoxicity (ADCC); Natural killer cells; Antibody therapy; Fc fucosylation;
Treatment of mice with human monoclonal antibody 24Â h after lethal aerosol challenge with virulent Venezuelan equine encephalitis virus prevents disease but not infection
Keywords: آنتی بادی درمان; Venezuelan equine encephalitis virus; Alphavirus; Human monoclonal antibody; Envelope glycoprotein; Antibody prophylaxis; Antibody therapy;
A standardized conversion of IgG antibody to bispecific form with inversely altered affinities for Fcγ-receptors II and III
Keywords: آنتی بادی درمان; ADCC; antibody-dependent cellular cytotoxicity; CMC; complement-mediated cytotoxicity; DTT; dithiothreitol; EMEM; Eagle's minimal essential medium; FcγR; Fcγ-receptor; FcRn; neonatal Fc-receptor; FTC; fluorescein isothiocyanate; mAb; monoclonal antibody
Human kappa light chain targeted Pseudomonas exotoxin A - identifying human antibodies and Fab fragments with favorable characteristics for antibody-drug conjugate development
Keywords: آنتی بادی درمان; Immunotoxin; Antibody-drug conjugate; Antibody screening; scFv; Pseudomonas exotoxin A; Antibody therapy;
Anti-tumor effects of depleting and non-depleting anti-CD27 monoclonal antibodies in immune-competent mice
Keywords: آنتی بادی درمان; CD27; T-cell co-stimulation; Antibody therapy; Cytotoxic T lymphocytes
Anti-infective antibodies—Reviving an old paradigm
Keywords: آنتی بادی درمان; Antibody therapy; Flu; Infantile diarrhoea
P-Selectin Inhibition Reduces Severity of Acute Experimental Pancreatitis
Keywords: آنتی بادی درمان; Acute pancreatitis; P-selectin; Antibody therapy;
Combination of rituximab with blinatumomab (MT103/MEDI-538), a T cell-engaging CD19-/CD3-bispecific antibody, for highly efficient lysis of human B lymphoma cells
Keywords: آنتی بادی درمان; Rituximab; Blinatumomab; Combination; Antibody therapy; Natural killer cells; T cells
Where to position monoclonal antibodies in first-line treatment of advanced colorectal cancer
Keywords: آنتی بادی درمان; Colorectal cancer; VEGF; EGFR; Antibody therapy; Targeted agents;
Preparation and use of therapeutic antibodies primarily of human origin
Keywords: آنتی بادی درمان; Immunoglobulins; Immunoglobulin intravenous; Immunoglobulin subcutaneous; Passive prophylaxis; Antibody therapy
I17 Treatment of acute lymphoblastic leukemia in adults
Keywords: آنتی بادی درمان; Acute lymphoblastic leukemia; Molecular targeting; Antibody therapy; Ph/bcrabl ALL; Minimal residual disease; Prognostic factors; Stem cell transplantation;
Midkine as a novel target for antibody therapy in osteosarcoma
Keywords: آنتی بادی درمان; MK, midkine; anti-MK antibody, goat polyclonal anti-midkine antibody; MRI, magnetic resonance imaging; ALP, alkaline phosphatase; PTN, pleiotrophinMidkine; Osteosarcoma; Prognosis; Antibody therapy
Mechanisms of Antibody Immunotherapy on Clonal Islet Reactive T Cells
Keywords: آنتی بادی درمان; Mechanism; antibody therapy; immunotherapy; autoimmunity; type 1 diabetes
Pentostatin/Cyclophosphamide with or Without Rituximab: An Effective Regimen for Patients with Waldenström's Macroglobulinemia/Lymphoplasmacytic Lymphoma
Keywords: آنتی بادی درمان; Antibody therapy; Immunocytoma; Maintenance treatment; Purine analogues;
Is antibody therapy of tumor compromised by infusion-related reactions?
Keywords: آنتی بادی درمان; Immunomodulation; Antibody therapy; Tumor; Intravenous IgG; Prostaglandin; Fcγ-receptor; Cyclooxygenase-2; Macrophage alternative activation; Th2 polarization;
Treatment with chimeric anti-human CD40 antibody suppresses MRI-detectable inflammation and enlargement of pre-existing brain lesions in common marmosets affected by MOG-induced EAE
Keywords: آنتی بادی درمان; EAE; CD40; Antibody therapy; Non-human primate;